4.5 Article

Neurological Recovery and Antioxidant Effects of Curcumin for Spinal Cord Injury in the Rat: A Network Meta-Analysis and Systematic Review

Journal

JOURNAL OF NEUROTRAUMA
Volume 32, Issue 6, Pages 381-391

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/neu.2014.3520

Keywords

network meta-analysis; spinal cord injury; curcumin; systematic review

Funding

  1. Ministry of Finance of People's Republic of China [201107004]
  2. National Basic Research Program of China (973 Program) [2010CB530400]
  3. Program for Changjiang Scholars and Innovative Research Team in University [IRT1270]
  4. Longhua Medical Team Project [LYTD-13]
  5. National Natural Science Foundation of China [81373666]
  6. Municipal Hospitals Cutting-edge Technologies Emerging Joint Project [SHDC12013113]
  7. Municipal Science and Technology Commission of Shanghai-TCM key project [14401970400]

Ask authors/readers for more resources

Spinal cord injury (SCI) is a devastating condition affecting young, healthy individuals worldwide. Existing agents have inadequate therapeutic efficacy, and some are associated with side effects. Our objective is to summarize and critically assess the neurological recovery and antioxidant effects of curcumin for treatment of SCI in rat models. PubMed, Embase, and Chinese databases were searched from their inception date to February 2014. Two reviewers independently selected animal studies that evaluated neurological recovery and antioxidant effects of curcumin, compared to placebo, in rats with SCI, extracted data, and assessed the methodological quality. A pair-wise analysis and a network meta-analysis were performed. Eight studies with adequate randomization were selected and included in the systematic review. Two studies had a higher methodological quality. Overall, curcumin appears to significantly improve neurological function, as assessed using the Basso, Beattie, Bresnahan (BBB) locomotor rating scale (four studies, n=132; pooled mean difference [MD]=3.09; 95% confidence interval [CI], 3.40-4.45; p=0.04), in a random-effects model and decrease malondialdehyde (MDA) using a fixed-effects model (four studies, n=56; pooled MD=-1.00; 95% CI=-1.59 to -0.42; p=0.00008). Effect size, assessed using the BBB scale, increased gradually with increasing curcumin dosage. The difference between low- and high-dose curcumin using the BBB scale was statistically significant. Neurological recovery and antioxidant effects of curcumin were observed in rats with SCI despite poor study methodological quality.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available